We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-UK faces worst weeks of COVID pandemic, accelerates vaccine rollout

Mon, 11th Jan 2021 07:42

* UK steps up vaccinations

* Next weeks of pandemic will be the worst - medical adviser

* UK concerned about spread of COVID-19 in supermarkets

* Medical adviser says UK situation is 'appalling'
(Adds Labour leader)

By Michael Holden

LONDON, Jan 11 (Reuters) - Britain is facing the worst weeks
of the COVID-19 pandemic, its chief medical officer said on
Monday, with the health service entering a "dangerous time" as
deaths and cases hit record highs while a mass vaccination
programme picks up steam.

Deaths from the virus have now exceeded 81,000 in the United
Kingdom - the world's fifth-highest toll - with more than 3
million people testing positive. A new, more transmissible
variant of the disease is surging through the population, with
one in 20 people in parts of London now infected.

In a bid to get on top of the pandemic and to try to restore
some degree of normality by the spring, Britain is rushing out
its largest ever vaccination programme, with shots to be offered
to all those in its top four priority categories - about 15
million people - by the middle of next month.

But the government's chief medical adviser Chris Whitty
warned the situation would deteriorate in the meantime.

"The next few weeks are going to be the worst weeks of this
pandemic in terms of numbers into the NHS (National Health
Service)," he said.

"Anybody who is not shocked by the number of people in
hospital who are seriously ill at the moment and who are dying
over the course of this pandemic, I think, has not understood
this at all. This is an appalling situation," he told BBC TV.

"SIGNIFICANT CRISIS"

During the peak of the first outbreak in April, about 18,000
people were in hospital but now there are 30,000, Whitty said,
adding the health service was facing "a significant crisis".

"Everybody says that this is the most dangerous time we've
really had in terms of numbers into the NHS," he said.

On Friday, London's mayor said the British capital's
hospitals were in danger of being overwhelmed by COVID patients,
and ministers and health chiefs have pleaded with people to
respect lockdown measures and stay at home unless it was
essential to go out.

Prime Minister Boris Johnson's government is pinning its
hopes on a mass vaccination programme to offer a way out of the
pandemic by the spring.

Britain was the first country to approve vaccines developed
by Oxford-AstraZeneca and by Pfizer/BioNTech
, and on Friday approved Moderna's shot. It
is aiming to offer shots to 15 million people by the middle of
next month.

To reach that target, which will require delivering 2
million vaccines a week, the government is opening seven big
vaccination centres while additional doctors' surgeries,
hospitals and some pharmacies will also start delivering shots.

"The vaccinations are really beginning to ramp up, 200,000 a
day, we've done an incredible job this past week," Nadhim
Zahawi, the minister in charge of the vaccination programme,
told Sky News.

Those in the four highest risk levels, including those over
70, the most clinically vulnerable and frontline health workers,
will be offered the vaccines by Feb. 15, he said.

"I hope they do. Let’s hold them to that," opposition Labour
leader Keir Starmer, who has repeatedly accused Johnson of being
too slow to respond to the pandemic, said of the target.

"Britain shouldn’t have one of the highest death tolls in
Europe, and the deepest recession. We shouldn’t be facing the
slowest recovery and we shouldn’t be suffering the tragedy of so
many deaths every day from this virus."

There have been calls for the government to take harder
action against those who break the lockdown rules, but Zahawi
said ministers did not want to "go any tougher". However, he
cautioned there was concern about the spread of the virus in
supermarkets and there was a need to ensure people wore masks
while in them.
(Additional reporting by Kate Holton, William Schomberg and
James Davey; writing by Michael Holden; editing by Estelle
Shirbon, Guy Faulconbridge and Angus MacSwan)

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.